ORBi: Detailled Reference

Article (Scientific journals)

Peut-on prevenir le developpement du cancer prostatique?

Bouffioux, Laurent; Willems, Evelyne; Waltregny, David

2003 • In Revue Médicale de Liège, 58 (4), p. 240-6

Peer reviewed

Permalink
https://hdl.handle.net/2268/4685

PubMed
12868328

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Pub#26 Rev Med Liège Prévention CaP 2003.pdf

Publisher postprint (463.86 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] Prostate cancer is the most frequent cancer in men living in industrialized countries. Numerous epidemiological and laboratory studies suggest that various hereditary, toxic, hormonal, and dietary factors may be involved in the development and/or progression of prostate cancer lesions. Several large prospective randomized trials for the chemo-prevention of prostate cancer are currently ongoing. In this review, data regarding the implication of dietary factors have been analyzed under the light of recent literature in order to determine whether proven efficient prevention is available today.

Disciplines :

Urology & nephrology

Author, co-author :

Bouffioux, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation

Willems, Evelyne ; Université de Liège - ULiège > Département des sciences cliniques > Hématologie

Waltregny, David ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Labo de recherche sur les métastases

Language :

French

Title :

Peut-on prevenir le developpement du cancer prostatique?

Alternative titles :

[en] Can the development of prostate cancer be prevented?

Publication date :

April 2003

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

58

Issue :

4

Pages :

240-6

Peer reviewed :

Peer reviewed

Available on ORBi :

since 24 January 2009

Statistics

Number of views

121 (6 by ULiège)

Number of downloads

2 (1 by ULiège)

More statistics

Scopus citations^®

0

Scopus citations^®
without self-citations

0

OpenAlex citations

1

Bibliography

MC Neal JE. - Origin and development of carcinoma in the prostate. Cancer, 1969, 23, 24.
Franks LM. - Latent carcinoma of the prostate. J Pathol Bacteriol, 1954, 68, 603-616.
Scott R, Mutchnik DL, Laskowski TZ, et al. - Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J Urol, 1969, 101, 602.
Breslow N, Chan CW, Dhom G, et al. - Latent carcinoma of prostate of autopsy in seven areas. Int J Cancer, 1977, 20, 680-8.
Dhom G. - Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol, 1983, 106, 210.
Seidman H, Mushinski MH, Gelb SK, et al. - Probabilities of eventually developing or dying of cancer - United States, 1985. CA Cancer J Clin, 1985, 35, 36-56.
Carter HB, Coffey DS. - The prostate: An increasing medical problem. Prostate, 1990, 16, 39-48.
Scardino PT, Weaver R, Hudson MA. - Early detection of prostate cancer. Hum Pathol, 1992, 23, 211-22.
Stamey TA, Freiha FS, McNeal JE, et al. - Localized prostate cancer: relationship of tumor volume to clinical significance for the treatment of prostate cancer. Cancer, 1993, 71, 993-998.
Epstein JI, Walsh PC, Carmichael M, et al. - Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA, 1994, 271, 368-74.
Kirby RS, Christmas TJ, Braxer M. - Anatomical and pathological considerations, in Greenwood G, Prostate cancer. Mosby TMIPL, ed, Turin, 1996, 3-21.
Ross RK, Paganini-Hill A, Henderson BE. - The etiology of prostate cancer: What does the epidemiology suggest? Prostate, 1983, 4, 333-344.
Akazaki K, Stemmermann GN. - Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst, 1973, 50, 1137.
Karr JP. - Prostate cancer in the United States and in Japan, in Prostate Cancer and Bone Metastasis, JP Karr, H Yamanaka, eds). Plenum Press, New York, 1992, 17-28.
Kirby RS, Christmas TJ, Brawer M. - Epidemiology and natural history of prostate cancer, in Greenwood G, Prostate cancer. Mosby TMIPL, ed, Turin, 1996, 23-31.
Ellis L, Nyborg H. - Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids, 1992, 57, 72-75.
Ross SK, Bernstein L, Lobo RA et al. - 5-alpha-reductase activity and risk of cancer among Japanese and US white and black males. Lancet, 1992, 339, 887-889.
Lytton B. - Demography of Prostatic Carcinoma, in The Prostate, JM Fitzpatrick, RJ Krane, eds. Churchill Livingstone, London, 1989, 253-259.
Albertsen K, Gronbaek M. - Does amount or type of alcohol influence the risk of prostate cancer? Prostate, 2002, 52, 297-304.
Boffetta P. - Methodological aspects of the epidemiological association between cadmium and cancer in humans. Report of the Intern. Agency for Res. on Cancer, Lyon, France, 1992, 425-434.
Committee to review the health effects in Vietnam Veterans of Exposure to herbicides. - Veterans and Agent Orange, Update 1996, Washington DC, Nat. Acad. Press, 1996.
Rosenberg L, Paler JR, Zauber AG, et al. - The relation of vasectomy to the risk of cancer. Amer J Epidem, 1994, 140, 431-438.
Heikkila R, Aho K, Heliovaara M, et al. - Serum testosterone and SHBG concentrations and the risk of prostate carcinoma. Cancer, 1999, 86, 312-315.
Kupelian P, Klein E, Witte JS, et al. - Familial prostate cancer: A different disease? J Urol, 1997, 158, 2197-2201.
Pienta KJ. - Epidemiology and etiology of prostate cancer, in Principles and practice of genito-urinary oncology, Raghavan D, Scher HI, Leibel SA et al., eds., Lippincot-Raven Publ., Philadelphia, 1997, 379-385.
Rose DP, Boyar AP, Wynder EL. - International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer, 1986, 58, 2363-2371.
Bairati I, Meyer F, Fradet Y, et al. - Dietary fat and advanced prostate cancer. Urology, 1998, 159, 1271-1275.
Giovannucci E, Ascherio A, Rimm EB, et al. - Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst, 1995, 87, 1767-1776.
Norrish AE, Skeaff CM, Arribas GL, et al. - Prostate cancer rtisk and comsumption of fish oils: A dietary biomarker-based case-control study. Brit J Cancer, 1999, 81, 1238-1242.
Cohen J, Kristal AR, Stanford JL, et al. - Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst, 2000, 92, 61-68.
Terry P, Lichtenstein P, Feychting M, et al. - Fatty fish consumption and risk of prostate cancer. Lancet, 2001, 357, 1764-66.
Shike M, Latkany L, Riedel L, et al. - Lack of effect of low-fat, high-fruit, vegetable and fiber diet on serum prostate specific antigen of men without prostate cancer: Results from a randomized trial. J Clin Oncol, 2002, 20, 3592-3598.
Agarwal S, Rao AV. - Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J, 2000, 163, 739-744.
Gerster H. - The potential role of lycopene for human health. J Am Coll Nutr, 1997, 16, 109-126.
Kucuk O, Sarkar FH, Sakr W, et al. - Phase II randomized trial of lycopene supplementation before radical prostatectomy. Cancer Epidem Biomarkers Prevention, 2001, 10, 861-868.
Jain MG, Hislop GT, Howe GR, et al. - Plant foods, anti-oxydants, and prostate cancer risk: Findings from case-control studies in Canada. Nutr Cancer, 1999, 34, 173-184.
Key TJ, Silcocks PB, Davey GK, et al. - A case control study of diet and prostate cancer. Brit J Cancer, 1997, 76, 678-687.
Kristal AR, Cohen JH. - Invited commentary: Tomatoes, lycopene, and prostate caner. How strong is the evidence? Am J Epidem, 2000, 151, 124-127.
Schwartz GG, Hulka BS. - Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res, 1990, 10, 1307.
Hanchette CL, Schwartz GG. - Geographic patterns of prostate cancer mortality: Evidence of a protective effect of ultraviolet radiation. Cancer, 1992, 70, 2861.
Braun MM, Helzlsouer KJ, Hollis BW, et al. - Prostate cancer and prediagnostic levels of serum vitamin D metabolites. Cancer Causes Control, 1995, 6, 235.
Gann PH, MA J, Hennekens CH, et al. - Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidem Biomarkers Prev, 1996, 5, 121.
De Primo SE, Shinghal R, Vidanes G, et al. - Prevention of prostate cancer. Prostate Cancer, 2001, 15, 445-457.
Israel K, Sanders BG, Kline K. - RRR-alpha-tocophéryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differenciation pathways. Nutr Cancer, 1995, 24, 161-169.
The ATBC Cancer Prevention Study Group. - The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med, 1994, 330, 1029-1035.
Blot WJ, Li JY, Taylor PR, et al. - Nutrition interventional trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst, 1993, 85, 1483-1492.
Shamberger RJ, Frost DV. - Possible protective effect of selenium against human cancer. Can Med Assoc J, 1969, 100, 682.
Mednews: www.meb.uni-bonn.de/cancernet. Prevention of prostate cancer. From the Natl Cancer Inst 208/05029, pp 1-18.
Clark LC, Combs GF Jr, Turnbull BW, et al. - Effect of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. JAMA, 1996, 276, 1957-1963.
Yoshizawa K, Willet WC, Morris SJ, et al. - Study of prediagnostic selenium levels in toe nails and the risk od advanced prostate cancer. J Natl Cancer Inst, 1998, 90, 1219.
Moyad MA. - Selenium and vitaminE supplements for prostate cancer: Evidence or embellishment? Urology, 2002, 59, 9-19.
Mantzoros CS, Tzonou A, Signorello LB, et al. - Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Brit J Cancer, 1997, 76, 1115-1118.
Chan JM, Stampfer MJ, Giovannucci E, et al. - Plasma insulin-like growth factor 1 and prostate cancer risk: A prospective study. Science, 1998, 279, 563-566.
Shi R, Berkel HJ, Yu H. - Insulin-like growth factor 1 and prostate cancer: A meta-analysis. Brit J Cancer, 2001, 85, 991-996.
Barinaga M. - Study suggests new way to gauge prostate cancer risk. Science, 1998, 279, 475.
Huggins C, Stevens R, Hodges C. - Studies on prostatic cancer. The effect of castration on advanced prostatic cancer. Arch Surg, 1941, 43, 209.
Thompson IM, Coltman CA Jr, Crowley J. - Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial. Prostate, 1997, 33, 217-221.
Andriole GL, Guess HA, Epstein JI, et al. - Treatment with finasteride preserves usefulness of prostatespecific antigen in the detection of prostate cancer. Results of a randomized, double-blind, placebo-controlled clinical trial. J Urol, 1998, 52, 195.
Cote RJ, Skinner EC, Salem CE, et al. - The effect of finasteride on the prostate gland in men with elevated serum prostatic specific antigen levels. Brit J Cancer, 1998, 78, 413.
Klein EA, Thompson IM, Lippman SM, et al. SELECT: The next prostate cancer prevention trial. J Urol, 2001, 166, 1311-1315.
Greenwald P. - Cancer prevention trials (American Cancer Society Award Lecture). J Clin Oncol, 2002, 2, 14s-22s.
Moyad MA. - Dietary fat reduction to reduce prostate cancer risk: Controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture. Urology, 2002, 59, 51-59.
Lieberman R, Bermejo C, Azaka H, et al. - Progress in prostate cancer chemoprevention: modulators of promotion and progression. Urology, 2001, 5, 835-842.

Similar publications